Serum CXCL6 as a biomarker for diagnosing and predicting progression of interstitial lung disease in ANCA-associated vasculitis. [PDF]
Li W +8 more
europepmc +1 more source
Hematologic and solid-organ malignancy risk in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. [PDF]
Mahajan A, Moslehi D, Bates DW.
europepmc +1 more source
ANCA-associated vasculitis in the United Arab Emirates: a 17-year case series with review from Gulf literature. [PDF]
Shahrour H +4 more
europepmc +1 more source
A fatal case of ANCA-associated vasculitis resulting in multiple organ failure: Case report and literature review. [PDF]
Chang WH, Chien SC, Chien SC, Hu TY.
europepmc +1 more source
Prevalence and clinical outcomes of fibrotic interstitial lung disease in ANCA associated vasculitis: a single-centre, retrospective, cohort study. [PDF]
Tirelli C +12 more
europepmc +1 more source
Functional classification of antineutrophil cytoplasmic antibody (ANCA) and its relation with clinical parameters of ANCA-associated vasculitis. [PDF]
Taniguchi M +20 more
europepmc +1 more source
Correction: Efficacy and safety of avacopan in the treatment of ANCA-associated vasculitis: a systematic review and meta-analysis. [PDF]
Aldhuaina K, Alghanim K.
europepmc +1 more source
Cytomegalovirus-induced severe enterocolitis associated with ANCA-associated vasculitis and diffuse alveolar haemorrhage in a child: a diagnostic and therapeutic dilemma. [PDF]
Ma D +7 more
europepmc +1 more source

